Stay updated on Relamorelin in Diabetic Gastroparesis Clinical Trial

Sign up to get notified when there's something new on the Relamorelin in Diabetic Gastroparesis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Relamorelin in Diabetic Gastroparesis Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study record related to the safety and efficacy evaluation of relamorelin for participants with vomiting symptoms and diabetic gastroparesis.
    Difference
    0.1%
    Check dated 2024-06-06T14:42:59.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for participants, specifying that researchers are looking for individuals with Type 1 or Type 2 diabetes mellitus and diabetic gastroparesis. Previously, no information was provided under the Participation Criteria section.
    Difference
    30%
    Check dated 2024-05-22T21:36:07.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2024-04-30T22:31:23.000Z thumbnail image

Stay in the know with updates to Relamorelin in Diabetic Gastroparesis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Relamorelin in Diabetic Gastroparesis Clinical Trial page.